MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Magnetic resonance imaging(MRI)"

  • MDS Virtual Congress 2020

    Development of Hypertrophic Olivary Degeneration Following Pontine Hemorrhage

    K. Bird, M.H Saint-Hilaire, G. Curiale, S. O'Shea (Boston, MA, USA)

    Objective: To increase awareness of the late post-stroke movement disorder associated with hypertrophic olivary degeneration. Background: A 65-year-old man with a past medical history significant…
  • MDS Virtual Congress 2020

    The relationship between neuromelanin-sensitive MRI, [123I] meta-iodobenzylguanidine scintigraphy and cognition, in patients with Parkinson’s disease

    T. Utsunomiya, K. Matsuura, Y. Ii, A. shindo, m. Umino, M. Maeda, H. Tomimoto (Tsu Mie, Japan)

    Objective: We investigate the relationship  between the contrast ratio of locus coeruleus (LC-CR) in neuromelanin-sensitive MRI(NMI), MIBG scintigraphy, and cognition/hallucination, in patients with Parkinson’s disease.…
  • MDS Virtual Congress 2020

    Quantitative Susceptibility Mapping for Differential Diagnosis of Degenerative Parkinsonisms: A Comparison with Morphometric Indexes

    S. Mazzucchi, E. Del Prete, M. Costagli, D. Frosini, D. Paoli, G. Donatelli, P. Cecchi, G. Migaleddu, U. Bonuccelli, M. Cosottini, R. Ceravolo (Pisa, Italy)

    Objective: To use a multimodal MRI approach for differential diagnosis of patients with degenerative parkinsonisms, comparing the diagnostic accuracy of Quantitative Susceptibility Mapping (QSM) data…
  • MDS Virtual Congress 2020

    Progression of cortical thinning in Parkinson’s disease

    A. Vo, C. Tremblay, S. Rahayel, Y. Yau, A. Dagher (Montréal, QC, Canada)

    Objective: We sought to validate cortical thickness as an objective biomarker of Parkinson’s disease (PD) progression. Background: Cortical thickness analysis has been proposed as a…
  • MDS Virtual Congress 2020

    Direct Targeting of the VIM Nucleus during High Intensity Focused Ultrasound (HIFU) by Direct Visualization

    Z. Zibly, S. Israeli Korn (Ramat Gan, Israel)

    Objective: To determine the “functional” target within  VIM Nucleus of the Thalamus during HIFU with high field MRI. Background: Targeting of neuronal structures has been…
  • MDS Virtual Congress 2020

    White matter abnormalities and its relation to cognitive impairment in isolated Rapid Eye Movement sleep behavior disorder

    A. Campabadal, B. Segura, A. Abos, C. Uribe, M. Serradell, C. Gaig, J. Santamaria, Y. Compta, C. Junqué, A. Iranzo (Barcelona, Spain)

    Objective: To study white matter (WM) abnormalities and global cortical atrophy in isolated rapid eye movement sleep behavior disorder (IRBD) patients and its relation to cognitive…
  • MDS Virtual Congress 2020

    Spatiotemporal Changes in Substantia Nigra Neuromelanin Content from Prodromal to Clinical Parkinson’s Disease

    E. Biondetti, R. Gaurav, L. Yahia-Cherif, G. Mangone, N. Pyatigorskaya, R. Valabrègue, C. Ewenczyk, M. Hutchison, C. François, J.C Corvol, M. Vidailhet, S. Lehéricy (Paris, France)

    Objective: To investigate the voxel-wise spatiotemporal changes in neuromelanin-sensitive MRI (NM-MRI) signal in the substantia nigra and their relation to clinical scores of disease severity…
  • MDS Virtual Congress 2020

    White matter microstructural abnormalities in tremor dominant and non-tremor dominant Parkinson’s disease

    P. Pal, S. Prasad, J. Saini (Bengaluru, India)

    Objective: To explore differences in white matter microstructural integrity in tremor dominant and non-tremor dominant Parkinson’s disease (PD) using tract based spatial statistics (TBSS). Background:…
  • MDS Virtual Congress 2020

    Normative vs. patient-specific brain connectivity in Deep Brain Stimulation

    Q. Wang, H. Akram, M. Muthuraman, G. Gonzalez-Escamilla, S. A. Sheth, G. Groppa, N. Vanegas-Arroyave, L. Zrinzo, N. Li, A. Kühn, A. Horn (Berlin, Germany)

    Objective: The objective of this study was to compare similarities and differences between patient-specific, disease-matched and normative structural connectivity seeding from deep brain stimulation (DBS)…
  • MDS Virtual Congress 2020

    Striatal neurodegeneration in the presymptomatic phase of X-linked Dystonia-Parkinsonism

    H. Hanssen, M. Heldmann, J. Dy, J. Tantianpact, J. Steinhardt, A. Sprenger, A. Domingo, C. Reyes, R. Rosales, C. Klein, T. Münte, A. Westenberger, J. Oropilla, C. Diesta, N. Brüggemann (Luebeck, Germany)

    Objective: To identify structural brain changes in patients with X-linked dystonia-parkinsonism (XDP) and non-manifesting carriers of the TAF1 SVA retrotransposon insertion (NMC). Background: XDP is…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 78
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley